Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Vertex Pharmaceuticals Incorporated (VRTX) had Return on Equity of 6.25% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.08B |
|
$1.08B |
|
$414.80M |
|
$2.66B |
|
$1.89B |
|
$1.19B |
|
$112.60M |
|
$1.30B |
|
$1.30B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.19B |
|
$1.24B |
|
255.60M |
|
257.60M |
|
$4.24 |
|
$4.20 |
|
| Balance Sheet Financials | |
$10.57B |
|
$1.43B |
|
$14.29B |
|
$24.86B |
|
$4.48B |
|
-- |
|
$3.07B |
|
$7.54B |
|
$17.32B |
|
$15.80B |
|
$17.32B |
|
253.95M |
|
| Cash Flow Statement Financials | |
$3.13B |
|
$-657.30M |
|
$-2.18B |
|
$4.57B |
|
$4.95B |
|
$375.60M |
|
$528.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.52% |
|
38.56% |
|
38.56% |
|
-- |
|
42.22% |
|
35.20% |
|
$2.85B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.26 |
|
1.58 |
|
56.94 |
|
|
Return on Equity |
6.25% |
6.85% |
|
4.36% |
|
6.25% |
|
$68.20 |
|
$11.04 |
|
$12.16 |
|